RBC Capital Reiterates Sector Perform on Medtronic, Maintains $92 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh reiterated a Sector Perform rating on Medtronic (MDT) and maintained a $92 price target.
February 21, 2024 | 3:37 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital maintains a Sector Perform rating on Medtronic with a $92 price target.
The reiteration of the Sector Perform rating and maintenance of the $92 price target by RBC Capital suggests a neutral outlook on Medtronic's stock in the short term. This indicates that the analyst believes the stock is fairly valued at its current level, neither undervalued nor overvalued, which is why the score is neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 90